Insiders Xintela AB

Equities

XINT

SE0007756903

Delayed Nasdaq Stockholm Other stock markets 08:00:04 14/05/2024 BST			5-day change	1st Jan Change
0.249 ^SEK	0.00%		-6.04%	-8.12%

02-28	Xintela AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-20	Xintela Names New Chief Scientific Officer	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xintela Names New Chief Scientific Officer	02-20	MT
Xintela Appoints Lucienne Vonk as Chief Scientific Officer	02-19	CI
Xintela AB Appoints Peter Ekolind as Acting CEO, Effective October 1, 2022	22/09/22	CI
New board of directors appointed in Targ	29/10/21	PU
New board of directors appointed in Targ	14/10/21	PU
Xintela AB Appoints Per Norlén as Chief Medical Officer from 1 July 2021	04/05/21	CI
Xintela Recruits Jeffrey Abbey to Targinta as Senior Management Advisor	14/12/20	CI
Xintela AB Appoints Lars Hedbys to Its Board of Directors	12/11/20	CI
Xintela AB Announces Executive Appointments	19/08/20	CI
Claes Post Decides Not to Stand for Re- Election as Board Member of Xintela AB	26/04/19	CI
Xintela AB Names Sven Kili as Chief Operating Officer	16/04/19	CI
Xintela Appoints Sven Kili as Chief Medical Officer	28/08/18	CI
Xintela AB Announces Resignation of Keld Søndergaard from the Board of Directors	17/10/17	CI
Xintela AB Appoints Liselotte Theorell as Director of Product Development and Quality Management	17/07/17	CI
Xintela AB Nominates Keld Sndergaard as New Board Member	09/05/17	CI
Xintela Recruits Rickard Mosell as Head of Business Development	12/09/16	CI
Xintela AB Appoints Caroline Ehrencrona as Director Clinical Development and Regulatory Affairs	01/06/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer